Life sciences organizations are often strained by the demand of regulatory complexity and maintaining compliance in different geographies. In addition, keeping up with the ever-changing regulatory landscape can be time-consuming and costly.
IQVIA provides regulatory, scientific, and medical advisory services (e.g., TPPs, CDPs, synopses, indication prioritization, and asset valuation) supported by our data and technology to enhance customer journeys from early drug development through submissions and post-registration.
RADDS span of services is global, and covers many regulatory agencies, from pre-INDs/IND/CTA investigational applications to BLA/NDA/MAA marketed application submissions, as well as post-registration services, including lifecycle management and regulatory operations.
Learn more by downloading the RADDS Fact Sheet.
Meet the challenge of changing stakeholder demands and increasing cost constraints with IQVIA's integrated technology services and analytics-driven offerings.
Automate and standardize your regulatory management, from correspondence and commitments to registration and tracking.
Reimagine regulatory service delivery.
